dr. davis on immunotherapy in her2-positive gastric/gej cancer
Published 4 years ago • 171 plays • Length 0:45Download video MP4
Download video MP3
Similar videos
-
0:22
copy of dr. davis on immunotherapy in her2-positive gastric/gej cancer
-
0:58
dr. davis on the potential for maintenance therapy in gastric cancer
-
1:25
dr. davis on caveats of the keynote-062 trial findings in gastric/gej cancer
-
3:54
beyond progression in her2-positive gastric/gej cancers
-
3:09
understanding her2’s role in gastric/gej cancer
-
3:52
her2-positive gastric cancer
-
1:34
dr. mehta on the current treatment paradigm in her2-positive gastric cancer
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
5:01
her2 gastric cancer
-
0:30
dr. grothey on trastuzumab for gastroesophageal cancer
-
1:33
dr. rimawi on the clinical need for immunotherapy in her2-positive breast cancer
-
5:16
goals of therapy in metastatic gastric/gej cancer
-
1:28
dr. tripathy on immunotherapy potential in her2-positive breast cancer
-
1:54
dr. janjigian on updated results from the destiny-gastric01 trial in her2 gastric cancer
-
0:50
dr. ellis on immunotherapy in her2 breast cancer
-
2:18
dr. george on the phase iii tags trial in gastric/gej cancer
-
1:08
dr. chung on the rationale of the keynote-811 trial in her2 gastric cancer
-
1:24
dr. catenacci on study of margetuximab plus pembrolizumab in gastric:gej cancer
-
5:54
gastric cancer: global perspectives on maintenance therapy